Stay updated with breaking news from Nasdaq Cert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Certara, Inc. (NASDAQ:CERT – Get Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 8,030,000 shares, an increase of 11.5% from the April 15th total of 7,200,000 shares. Approximately 10.3% of the shares of the company are short sold. Based on an […]
Certara, Inc. (NASDAQ:CERT – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 8,030,000 shares, a growth of 11.5% from the April 15th total of 7,200,000 shares. Based on an average daily volume of 1,460,000 shares, the short-interest ratio is currently […]
Certara, Inc. (NASDAQ:CERT – Get Rating) SVP Richard M. Traynor sold 5,000 shares of Certara stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $20.82, for a total transaction of $104,100.00. Following the sale, the senior vice president now directly owns 177,368 shares of the […]
Certara, Inc. (NASDAQ:CERT – Get Rating) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 8,030,000 shares, a growth of 11.5% from the April 15th total of 7,200,000 shares. Based on an average trading volume of 1,460,000 shares, the short-interest ratio is presently […]
Certara (NASDAQ:CERT – Get Rating) and Information Analysis (OTCMKTS:IAIC – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership. Insider & Institutional Ownership 75.4% of Certara shares are held by […]